List of Excipients in API diltiazem hydrochloride extended release
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing diltiazem hydrochloride extended release
Detailed excipient profiles for diltiazem hydrochloride extended release
Excipient focus: CELLULOSE, MICROCRYSTALLINE
diltiazem hydrochloride extended release drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
diltiazem hydrochloride extended release drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
diltiazem hydrochloride extended release drug variants containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
diltiazem hydrochloride extended release drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C GREEN NO. 3
diltiazem hydrochloride extended release drug variants containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
diltiazem hydrochloride extended release drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
diltiazem hydrochloride extended release drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
diltiazem hydrochloride extended release drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
diltiazem hydrochloride extended release drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
diltiazem hydrochloride extended release drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
diltiazem hydrochloride extended release drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
diltiazem hydrochloride extended release drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE STEARATE
diltiazem hydrochloride extended release drug variants containing SUCROSE STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing SUCROSE STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
diltiazem hydrochloride extended release drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
diltiazem hydrochloride extended release drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| direct rx | diltiazem hydrochloride extended release | 72189-248 |
| >Company | >Ingredient | >NDC |
diltiazem hydrochloride extended release drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links